Evidence map›Paper›PMID 28144883›Full record

ArticleInternational journal of clinical oncology2017

Retrospective analysis of lung cancer patients treated with supportive care alone.

Hironori Ashinuma, Masato Shingyoji, Yasushi Yoshida, Meiji Itakura, Toshihiko Iizasa, Yoshihiko Sakashita, Ikuo Sekine

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hironori AshinumaDivision of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan. hashinuma@chiba-cc.jp.
Masato ShingyojiDivision of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan.
Yasushi YoshidaDivision of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan.
Meiji ItakuraDivision of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan.
Toshihiko IizasaDivision of Thoracic Surgery, Chiba Cancer Center, Chiba, Japan.
Yoshihiko SakashitaDivision of Palliative Care, Chiba Cancer Center, Chiba, Japan.
Ikuo SekineDivision of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan.
Chiba Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is not uncommon for patients with lung cancer to receive supportive care alone. However, the clinical characteristics of these patients have not been fully studied. We conducted a retrospective study to identify the clinical characteristics of definitive lung cancer patients treated with supportive care alone.

methodsWe retrospectively analyzed the percentage of and reasons for definitive lung cancer patients treated with supportive care alone at a regional cancer center. We also investigated the histological diagnostic approaches, palliative therapy types, primary treatment locations after hospital consultation, and places of death.

resultsA total of 1,223 patients were histologically diagnosed as having lung cancer between 2011 and 2014. Of these, 160 (13%) patients were treated with supportive care alone. The primary reason for treatment with supportive care alone was a poor performance status (PS) in almost half of the patients. Overall, 40% of the patients received supportive care at home, and 17% were admitted to a palliative care unit (PCU). Death occurred at home for 17% of the patients and in the PCU for 42% of the patients.

conclusionThis study revealed that 13% of histologically proven lung cancer patients were treated with supportive care alone, mostly because of a poor PS. Only 40% of these patients received home care, suggesting the need for a more accessible home care system for patients and their families.

Indexed as

AdultAgedAnti-Inflammatory Agents, Non-SteroidalFemaleHumansJapanLung NeoplasmsMaleMiddle AgedNarcoticsPalliative CareRetrospective StudiesSurvival RateAnti-Inflammatory Agents, Non-SteroidalNarcoticsHome careLung cancerPalliative care unitPalliative therapySupportive care

Identifiers

PMID28144883
OpenAlexW2584709139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.